Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration

      Highlights

      • More than 25% of patients with COVID-19 were asymptomatic.
      • Among patients with COVID-19, 26.1% presented anosmia, and 22.6% complained of ageusia with median duration of 7 days.
      • Mean duration of SARS-CoV-2 viral shedding was 24.5 days.
      • Irrespective of clinical manifestations, all patients with COVID-19 showed prolonged viral shedding.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Song J.Y.
        • Yun J.G.
        • Noh J.Y.
        • Cheong H.J.
        • Kim W.J
        Covid-19 in South Korea - challenges of subclinical manifestations.
        N Engl J Med. 2020; https://doi.org/10.1056/NEJMc2001801
        • Huang L.
        • Zhang X.
        • Zhang X.
        • et al.
        Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study.
        J Infect. 2020; https://doi.org/10.1016/j.jinf.2020.03.006
        • Giacomelli A.
        • Pezzati L.
        • Conti F.
        • et al.
        Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study.
        Clin Infect Diseas Offic Publ Infect Diseases Soc Am. 2020; https://doi.org/10.1093/cid/ciaa330
        • Mizumoto K.
        • Kagaya K.
        • Zarebski A.
        • Chowell G
        Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan.
        Euro Surveill. 2020; 25https://doi.org/10.2807/1560-7917.es.2020.25.10.2000180
        • Luers J.C.
        • Klussmann J.P.
        • Guntinas-Lichius O
        The Covid-19 pandemic and otolaryngology: what it comes down to?.
        Laryngorhinootologie. 2020; https://doi.org/10.1055/a-1095-2344
        • Deems D.A.
        • Doty R.L.
        • Settle R.G.
        • et al.
        Smell and taste disorders, a study of 750 patients from the University of pennsylvania smell and taste center.
        Arch. Otolaryngol. Head Neck Surg. 1991; 117: 519-528https://doi.org/10.1001/archotol.1991.01870170065015
        • Suzuki M.
        • Saito K.
        • Min W.P.
        • et al.
        Identification of viruses in patients with postviral olfactory dysfunction.
        Laryngoscope. 2007; 117: 272-277https://doi.org/10.1097/01.mlg.0000249922.37381.1e
        • Netland J.
        • Meyerholz D.K.
        • Moore S.
        • Cassell M.
        • Perlman S
        Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.
        J. Virol. 2008; 82: 7264-7275https://doi.org/10.1128/jvi.00737-08
        • Xu H.
        • Zhong L.
        • Deng J.
        • et al.
        High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.
        Int J Oral Sci. 2020; 12: 8https://doi.org/10.1038/s41368-020-0074-x
        • Liu L.
        • Wei Q.
        • Alvarez X.
        • et al.
        Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.
        J Virol. 2011; 85: 4025-4030https://doi.org/10.1128/jvi.02292-10